DailyIQ
Last updatedjust now

COO·The Cooper Companies, Inc.

$54.19
+0.28 (+0.52%)
Overnight$54.19+0.00 (+0.00%)
High
$54.99
Open
$54.78
Market Cap
10.25B
52W High
$90.00
Low
$53.23
P. Close
$54.19
P/E
17.98
52W Low
$51.01
Fwd P/E
11.49
DailyIQ Est.
$67.25
Inst. Ownership
0.0%
Short Interest
4.04%
Days to Cover
4.1
Technical Score (1D)
0
SELL
News Sentiment
32
BEARISH
The Cooper Companies’ latest quarterly report, released just 1½ hours ago, shows a modest uptick in overseas revenue, driven by steady demand for its surgical and contact‑lens products abroad. This growth in the international segment provides a tailwind that could help offset domestic headwinds, but the increase is not yet large enough to materially shift the company’s earnings guidance. Currency fluctuations and geopolitical risks remain a concern, as they could erode the gains from foreign sales if exchange rates weaken or regional instability rises. The diversified geographic footprint, however, offers a cushion against local economic downturns, reducing the risk of a sharp revenue decline in any single market. Over the next 1–10 trading days, traders should watch for any updates on the company’s guidance, particularly whether COO will adjust its revenue or earnings forecasts upward in light of the overseas momentum. Additionally, keep an eye on currency movements, especially the USD against major currencies in key markets, as this will directly impact the reported foreign revenue figures. Finally, monitor any commentary from COO’s management on how they plan to capitalize on the international growth, such as new product launches or market expansions, which could signal further upside potential.
Earnings Summary
Cooper Companies, Inc. is a global medical device firm with two primary segments: vision care through CooperVision and women’s health via CooperSurgical, offering contact lenses and fertility solutions. The company operates within the broader healthcare and medical instruments sector, serving a diverse network of distributors and healthcare professionals. In the most recent quarters, Cooper Companies posted EPS of $0.92 in Q4 2024, $0.96 in Q1 2025, $1.10 in Q2 2025, and $1.15 in Q3 2025, each beating analyst estimates and showing a steady upward trajectory; revenue rose from $964.7 million in Q4 2024 to $1.0653 billion in Q3 2025, a 10.5% YoY increase. The company has consistently outperformed expectations in the last four quarters, with EPS beats in all four periods and revenue growth maintained even when guidance remained flat. Historically, Cooper Companies has delivered double‑digit revenue growth while maintaining EPS beats, reflecting disciplined cost management and successful product launches. Recent news highlights a modest earnings beat forecast for Q3 2026, with guidance of $1.11 per share and $1.1 billion in revenue, and mentions potential divestiture of the CooperSurgical unit, which could unlock value. Investors should watch for any revisions to guidance or commentary on margin drivers in the upcoming earnings release, as well as updates on the CooperSurgical divestiture, which could materially affect short‑term sentiment. Key will be how the company translates recent product launches into tangible margin gains and whether the AI‑driven operational tools and HSA asset growth continue to support cost control and revenue expansion.

EPS

EstBeatMiss
$1.00$1.06$1.12$1.18$1.24Q2'25Q3'25Q1'26Q2'26Q3'26Q4'25
QtrEstActual+/−
Q4'25$1.03 - -
Q3'26$1.12$1.15+2.7%
Q2'26$1.11$1.21+9.3%
Q1'26$1.04$1.10+5.7%
Q3'25$1.11$1.15+3.3%
Q2'25$1.07$1.10+3.0%

Revenue

EstBeatMiss
$1.0B$1.0B$1.1B$1.1B$1.1BQ2'25Q3'25Q1'26Q2'26Q3'26Q4'25
QtrEstActual+/−
Q4'25$1.0B - -
Q3'26$1.1B$1.1B-3.9%
Q2'26$1.1B$1.1B+1.6%
Q1'26$1.0B$1.0B-1.2%
Q3'25 - $1.1B -
Q2'25 - $1.1B -

Market Data

COO Stock Snapshot

SELL0/100
$54.19+$0.00 (0.0%)
Market cap
10.25B
P/E ratio
18.0
Day range
$53.23 – $54.99
News sentiment
32/100 · Bearish
Analyst target
$66.21 (+22.2%)
Consensus
Hold · 25 analysts
52-week range+6.2% off low · -39.8% from high
$51.01$90.00
Price $54.19 DailyIQ Est. $67.25

The chart on COO has not stabilised: price is near its 52-week low and the trend is still down. Earnings and guidance carry more weight than macro data at this capitalisation.

Reverse DCF

What growth is priced into COO?

RICH

At today's price, The Cooper Companies, Inc. needs to grow free cash flow about 13.1% a year for the next 10 years to justify its valuation at a 7.82% cost of capital. Over its actual history it has compounded free cash flow at 5.2% a year, so the market is asking for 7.9 percentage points above its own delivered rate. On that basis COO looks priced above what its own growth record supports.

Implied FCF growth
13.1%
Historical FCF CAGR
5.2%
Growth gap
+7.9 pts
Verdict
RICH
Discount rate (WACC)
7.82%
Beta
0.82

Behaviour On Record

What COO's own history says about today's numbers

Realized volatility (21d)
58.5% 98th pct
vs 200-day average
-26.4%
Up days (1y)
44%

The Cooper Companies, Inc. is currently running 58.5% annualised volatility over the last 21 sessions. Measured against COO's own 3 years of daily returns rather than a market-wide average, that is the 98th percentile an extreme by its own standards, against a typical reading of 26.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

Price sits -26.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 1st percentile a narrower gap than it typically runs. Over the past year COO closed higher on 44% of sessions, and it is currently 5 sessions into a falling streak.

Overnight risk is measurable too: COO has opened more than 2% away from the prior close in 38 of 743 sessions (5.1% of the time), with the largest gaps running +6.6% and -18.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 4 dated reports on file, COO moved an average of 6.6% in the session after earnings, closing higher 1 of those 4 times, with a median move of -4.4% and a largest of -14.7%.

All figures computed from 744 daily closes between 2023-09-26 and 2026-09-14, split-adjusted, recomputed daily. Percentiles are against COO's own 3-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of COO's sector?

The Cooper Companies, Inc. sits in the Health Care sector, currently ranked 3rd of 11 GICS sectors by relative-strength rotation score (weakening).

Sector rank
#3 of 11
Sector state
Weakening
Sector rotation score
70

Analyst Rating Changes

Are analysts turning bullish or bearish on COO?

William Blair most recently downgraded The Cooper Companies, Inc. to Market Perform on Sep 10, 2026. Over the last 90 days, coverage has run 0 upgrades against 4 downgrades, a net bearish lean.

Latest action
William BlairMarket Perform
90-day upgrades
0
90-day downgrades
4
Net rating momentum
-4
DateFirmActionRatingPrice target
Sep 10, 2026William BlairDowngradeOutperform → Market Perform-
Sep 10, 2026Wells FargoMaintainedEqual-Weight$66 → $61
Sep 10, 2026StifelMaintainedBuy$85 → $70
Sep 10, 2026CitigroupMaintainedNeutral$80 → $60
Sep 10, 2026Piper SandlerDowngradeOverweight → Neutral$86 → $59
Sep 10, 2026JP MorganMaintainedNeutral$71 → $58
Sep 10, 2026UBSMaintainedNeutral$75 → $66
Sep 10, 2026B of A SecuritiesDowngradeBuy → Neutral$80 → $65
Sep 10, 2026BairdDowngradeOutperform → Neutral$85 → $61
Sep 10, 2026NeedhamMaintainedBuy$86 → $73
Aug 13, 2026CitigroupMaintainedNeutral$76 → $80
Jul 28, 2026UBSInitiatedNeutral$75

COO Competitive Positioning

The Cooper Companies, Inc. (COO) is tracked alongside these names in Medical Instruments & Supplies on DailyIQ — ranked by market cap, with today's move alongside.

Held by These ETFs

COO is a top holding in these ETFs tracked on DailyIQ — bar length shows portfolio weight.